newsfilter
← Latest News
Business Wire·

Acorda Therapeutics to Conduct 1-for-20 Reverse Stock Split

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it will conduct a reverse stock split of its outstanding and authorized shares of common stock at a ratio of 1-for-20. The reverse stock split will become